Every year, thousands of people in Europe and the USA are infected and diagnosed with Lyme disease. It can also be assumed that the number of unknown cases is high. The main reason is the limitation in diagnostics of this malicious disease.
Lyme disease, also known as Lyme borreliosis, is an infectious disease transmitted by ticks. It can take years to identify and correctly diagnose this disease. This is mainly due to its unspecific symptoms, that is to say, the symptoms can also be associated with many other conditions.
This can have a devastating effect on the body, as, during this time, the pathogens of Lyme disease can spread in the body, cause severe damage, and transform into persistent forms. This is problematic because, in these persistent forms, bacteria are “hidden” from the human immune system and are much more resistant to conventional therapy, which is usually limited to the administration of antibiotics. Therefore, when Lyme disease has finally been diagnosed, an antibiotic therapy in accordance with treatment guidelines does not usually have the desired effect.
In Cellular Medicine, selected micronutrients (cellular nutrients) are combined in accordance with the principle of nutrient synergy in order to achieve a positive impact on health. In 2016, together with a private medical institution for the diagnosis and treatment of Lyme disease, we conducted an observational study to investigate the efficacy of a specific micronutrient combination against the bacteria of Borrelia, pathogens causing Lyme disease. The study lasted 6 months and included 17 Lyme disease patients with mainly severe symptoms. In the first 5 weeks, IPT (insulin potentiated therapy), a standard approach in this private institution, was used in parallel with the micronutrient combination. Subsequently, the focus of the treatment was directed at the use of cellular nutrients.
The study results speak for themselves: after 6 months of taking cellular nutrients, almost half of the participants showed a significant improvement in health. Continuing the synergistic use of plant substances and micronutrients is therefore advisable. About 20 % of the participants reported to be completely free of symptoms after an application period of 6 months.
11.8 % of the patients experienced a moderate improvement of their health, whilst 23.5 % felt no improvement. A small number of participants terminated micronutrient application early. Considering the fact that virtually no improvements are known from the conventional treatment of advanced Lyme disease, these results are highly significant.
In spite of the severity of symptoms in all patients at the beginning of the study, about two-thirds (64.7 %) of the participants reported a substantial improvement of their health after 6 months of using micronutrients. Therefore, the therapists involved in the study concluded that the synergistic use of plant substances and micronutrients should be included as a long-term treatment in every therapeutic approach to Lyme disease.
Particularly noteworthy is the result that plant substances and micronutrients are not only highly effective in early phases of Lyme disease, but also in its advanced stages when common antibiotic therapies reach their limits. Once more, this proves the superiority of natural substances over conventional therapies.
1. In vitro evaluation of antibacterial activity of phytochemicals and micronutrients against Borrelia burgdorferi and Borrelia garinii, A. Goc, A. Niedzwiecki and M. Rath, 2015, Journal of Applied Microbiology, 119(6):1561-1572
2. The anti-borreliae efficacy of phytochemicals and micronutrients: an update, A. Goc and M. Rath, 2016, Therapeutic Advances in Infectious Disease, 3(3-4):75-82